MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.07
-0.85 (-6.58%)
Sep 5, 2025, 12:34 PM - Market open

MBX Biosciences Statistics

Total Valuation

MBX Biosciences has a market cap or net worth of $405.48 million. The enterprise value is $209.78 million.

Market Cap405.48M
Enterprise Value 209.78M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

MBX Biosciences has 33.59 million shares outstanding. The number of shares has increased by 2,182.51% in one year.

Current Share Class 33.59M
Shares Outstanding 33.59M
Shares Change (YoY) +2,182.51%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) 3.14%
Owned by Institutions (%) 56.47%
Float 14.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.98
P/TBV Ratio 1.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.50, with a Debt / Equity ratio of 0.00.

Current Ratio 19.50
Quick Ratio 19.20
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -56.28% and return on invested capital (ROIC) is -39.40%.

Return on Equity (ROE) -56.28%
Return on Assets (ROA) -36.75%
Return on Invested Capital (ROIC) -39.40%
Return on Capital Employed (ROCE) -39.39%
Revenue Per Employee n/a
Profits Per Employee -$1.79M
Employee Count43
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 13.12
200-Day Moving Average 12.52
Relative Strength Index (RSI) 45.95
Average Volume (20 Days) 330,310

Short Selling Information

The latest short interest is 4.07 million, so 12.10% of the outstanding shares have been sold short.

Short Interest 4.07M
Short Previous Month 5.34M
Short % of Shares Out 12.10%
Short % of Float 27.83%
Short Ratio (days to cover) 8.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -86.56M
Pretax Income -47.20M
Net Income -77.02M
EBITDA -86.29M
EBIT -86.56M
Earnings Per Share (EPS) -$2.88
Full Income Statement

Balance Sheet

The company has $224.91 million in cash and $650,000 in debt, giving a net cash position of $224.26 million or $6.68 per share.

Cash & Cash Equivalents 224.91M
Total Debt 650,000
Net Cash 224.26M
Net Cash Per Share $6.68
Equity (Book Value) 219.24M
Book Value Per Share 6.53
Working Capital 217.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$70.81 million and capital expenditures -$886,000, giving a free cash flow of -$71.70 million.

Operating Cash Flow -70.81M
Capital Expenditures -886,000
Free Cash Flow -71.70M
FCF Per Share -$2.13
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBX Biosciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,182.51%
Shareholder Yield -2,182.51%
Earnings Yield -17.74%
FCF Yield -16.52%

Analyst Forecast

The average price target for MBX Biosciences is $37.38, which is 209.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $37.38
Price Target Difference 209.69%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2